好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Comparative Efficacy of Antiepileptic Drugs in patients with Status Epilepticus admitted to the Neurocritical Care Unit
Neurocritical Care
P6 - (-)
070
Authors/Disclosures
Shishir K. Rao, MD (Wellstar Health Sciences)
PRESENTER
The institution of Dr. Rao has received research support from Eisai, Inc.
Advait Mahulikar, MD (Mercy Neurology) No disclosure on file
Kushak Suchdev, MD Dr. Suchdev has nothing to disclose.
Deepti Zutshi, MD, FAAN (Wayne State University School of Medicine) Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Aashit K. Shah, MD, FAAN (Carilion Clinic) Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma.
Navid Seraji-Bozorgzad, MD (University of Michigan Medicine-Neurology) No disclosure on file
Wazim Mohamed, MD (Detroit Medical Center/Wayne State University) Dr. Mohamed has nothing to disclose.